Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.

Joaquin Mateo, Suneil Jain, Emma Hall, Johann S de Bono

Research output: Contribution to conferencePaper

Original languageEnglish
Pages141
Publication statusPublished - 20 Feb 2017
EventGU ASCO Symposium - F, Orlando, United States
Duration: 09 Feb 201711 Feb 2017

Conference

ConferenceGU ASCO Symposium
Abbreviated titleGU ASCO
CountryUnited States
CityOrlando
Period09/02/201711/02/2017

Cite this

@conference{400db754721a4b108416ff4c95c73fa1,
title = "Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.",
author = "Joaquin Mateo and Suneil Jain and Emma Hall and {de Bono}, {Johann S}",
year = "2017",
month = "2",
day = "20",
language = "English",
pages = "141",
note = "GU ASCO Symposium, GU ASCO ; Conference date: 09-02-2017 Through 11-02-2017",

}

Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial. / Mateo, Joaquin; Jain, Suneil; Hall, Emma; de Bono, Johann S.

2017. 141 Paper presented at GU ASCO Symposium, Orlando, United States.

Research output: Contribution to conferencePaper

TY - CONF

T1 - Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.

AU - Mateo, Joaquin

AU - Jain, Suneil

AU - Hall, Emma

AU - de Bono, Johann S

PY - 2017/2/20

Y1 - 2017/2/20

M3 - Paper

SP - 141

ER -